Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $3.5 to $3.2.
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $3.5 to $3.2.